Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Dena R. Ramey"'
Autor:
Tracey Weiss, Dena R. Ramey, Ngan Pham, Nazneen Fatima Shaikh, Dajun Tian, Xiaohui Zhao, Aimee M. Near, Dominik Lautsch, Steven D. Nathan
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 2, Pp n/a-n/a (2024)
Abstract This retrospective study was conducted to evaluate all‐cause healthcare resource utilization (HCRU) and costs in commercially insured patients living with pulmonary arterial hypertension (PAH) and explore end‐of‐life (EOL)‐related HC
Externí odkaz:
https://doaj.org/article/e1731666b6cb444782d67050c24c44a5
Autor:
Janet Pope, Stephen Hall, Claire Bombardier, Boulos Haraoui, Graeme Jones, Latha Naik, Carol J. Etzel, Dena R. Ramey, Ricardo Infante, Maia Miguelez, Stephanie Falcao, Sevag Sahakian, David Wu
Publikováno v:
Advances in therapy. 39(11)
To better inform clinicians about the use of etanercept biosimilar (SB4) in patients with rheumatoid arthritis (RA), COMPANION-B, a prospective real-world observational study, evaluated the effectiveness of the voluntary switch from originator (etane
Autor:
Murray Baron, Marvin J. Fritzler, Evelyn Sutton, Boyang Zheng, Tatiana S. Rodriguez-Reyna, Dena R. Ramey, David Robinson, Carter Thorne, Ariel Masetto, Marie Hudson, Paul R. Fortin, Maggie Larché, Carl A Baxter, Geneviève Gyger, Janet E. Pope, Nader Khalidi, Tatiana Nevskaya, Doug Smith
Publikováno v:
Rheumatology. 59:398-406
Objective To determine whether skin score changes are associated with changes in overall disease severity, function and quality of life in early dcSSc patients. Methods A total of 154 and 128 dcSSc patients from the Canadian Scleroderma Research Grou
Autor:
Martha Emneus, Daniel Mines, Kristian Aasbjerg, Annette Kjær Ersbøll, Joanne E. Brady, Christian Vestergaard, Alfred Peter Born, Kaushik Sengupta, Eline Aas, Kristian Bolin, Thora Majlund Kjærulff, Eero Pukkala, Gunnar Gislason, Dena R. Ramey
Publikováno v:
Ersbøll, A K, Sengupta, K, Pukkala, E, Bolin, K, Aas, E, Emneus, M, Ramey, D R, Brady, J E, Mines, D, Aasbjerg, K, Vestergaard, C, Gislason, G, Born, A P & Kjærulff, T M 2021, ' Desloratadine Exposure and Incidence of Seizure : A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015 ', Drug Safety, vol. 44, no. 11, pp. 1231-1242 . https://doi.org/10.1007/s40264-021-01106-7
Ersbøll, A K, Sengupta, K, Pukkala, E, Bolin, K, Aas, E, Emneus, M, Ramey, D R, Brady, J E, Mines, D, Aasbjerg, K, Vestergaard, C, Gislason, G, Born, A P & Kjærulff, T M 2021, ' Desloratadine Exposure and Incidence of Seizure : A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015 ', Drug Safety, vol. 44, no. 11, pp. 1231-1242 . https://doi.org/10.1007/s40264-021-01106-7
Ersbøll, A K, Sengupta, K, Pukkala, E, Bolin, K, Aas, E, Emneus, M, Ramey, D R, Brady, J E, Mines, D, Aasbjerg, K, Vestergaard, C, Gislason, G, Born, A P & Kjærulff, T M 2021, ' Desloratadine Exposure and Incidence of Seizure : A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015 ', Drug Safety, vol. 44, pp. 1231–1242 . https://doi.org/10.1007/s40264-021-01106-7
Drug Safety
Ersbøll, A K, Sengupta, K, Pukkala, E, Bolin, K, Aas, E, Emneus, M, Ramey, D R, Brady, J E, Mines, D, Aasbjerg, K, Vestergaard, C, Gislason, G, Born, A P & Kjærulff, T M 2021, ' Desloratadine Exposure and Incidence of Seizure : A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001–2015 ', Drug Safety, vol. 44, no. 11, pp. 1231-1242 . https://doi.org/10.1007/s40264-021-01106-7
Ersbøll, A K, Sengupta, K, Pukkala, E, Bolin, K, Aas, E, Emneus, M, Ramey, D R, Brady, J E, Mines, D, Aasbjerg, K, Vestergaard, C, Gislason, G, Born, A P & Kjærulff, T M 2021, ' Desloratadine Exposure and Incidence of Seizure : A Nordic Post-authorization Safety Study Using a New-User Cohort Study Design, 2001-2015 ', Drug Safety, vol. 44, pp. 1231–1242 . https://doi.org/10.1007/s40264-021-01106-7
Drug Safety
Introduction A small number of adverse events of seizure in patients using desloratadine (DL) have been reported. The European Medicines Agency requested a post-authorization safety study to investigate whether there is an association between DL expo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::81d2768c4457d274c06ea3ff5c571e9d
https://trepo.tuni.fi/handle/10024/134927
https://trepo.tuni.fi/handle/10024/134927
Autor:
Mehul D. Patel, Panagiotis Mavros, Harold E. Bays, Dena R. Ramey, Joanne E. Tomassini, Andrew M. Tershakovec, Carl A Baxter
Publikováno v:
Journal of Clinical Lipidology. 11:929-937
Background The 2008 Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) study demonstrated ezetimibe + simvastatin vs simvastatin alone had a neutral effect on the surrogate endpoint of carotid intima-media
Autor:
David Wu, Denis Choquette, Sevag Sahakian, Jin Ju Kim, Dena R. Ramey, Angela Lai, Marc Egeth, Jennifer Soosaar, Peter Nash, Ricardo Infante
Publikováno v:
Advances in Therapy
Introduction Brenzys was developed as an etanercept biosimilar of Enbrel. The aim of this study was to assess preference and perceived ease of use for the new Brenzys autoinjector compared to the currently available marketed Enbrel MYCLIC autoinjecto
Publikováno v:
Rheumatology. 59:1783-1784
Publikováno v:
Rheumatology (Oxford, England). 59(7)
ObjectivesSkin improvement in diffuse cutaneous SSc (dcSSc), measured with modified Rodnan skin score (mRSS), is frequently used as a primary outcome in clinical trials, but it is uncertain whether mRSS changes reflect changes in other organ systems.
Autor:
Cynthia Macahilig, Ishita Doshi, Kaan Tunceli, Jyoti Aggarwal, Ruben Burgos-Vargas, Kelly D Johnson, Fidel Lozano, Dena R. Ramey
Publikováno v:
Reumatologia clinica. 17(7)
Introduction and objectives There is limited data that characterizes osteoarthritis (OA) patients who experience moderate to severe pain despite analgesic treatment in Mexico. In this study, we estimate the real-world prevalence of inadequate pain re
Autor:
L. Lévy-Bachelot, Stève Bénard, S. Teal, D. Avot, Olivier Sitbon, C. A. Baxter, Dena R. Ramey, Laura Catella, Vincent Cottin
Publikováno v:
PLoS ONE, Vol 14, Iss 4, p e0214649 (2019)
Chronic thromboembolic pulmonary hypertension (CTEPH), a rare pulmonary vascular disease, is often misdiagnosed due to nonspecific symptoms. The objective of the study was to develop, refine and validate a case ascertainment algorithm to identify CTE